Company Filing History:
Years Active: 2017-2018
Title: Nathan Ide: Innovator in Anti-Viral Compounds
Introduction
Nathan Ide is a notable inventor based in Lindenhurst, IL (US). He has made significant contributions to the field of anti-viral research, particularly focusing on compounds that target the Hepatitis C virus (HCV). With a total of two patents to his name, Ide's work is crucial in the ongoing battle against viral infections.
Latest Patents
Nathan Ide's latest patents revolve around anti-viral compounds that are effective in inhibiting the activity of HCV polymerase. These inventions not only include the compounds themselves but also detail the processes for making these compounds, compositions that comprise them, and methods for using them to treat HCV infections. His innovative approach has the potential to improve treatment options for those affected by this virus.
Career Highlights
Ide is currently associated with AbbVie Inc., a leading biopharmaceutical company. His work at AbbVie has allowed him to focus on developing groundbreaking solutions in the field of virology. His dedication to research and innovation has positioned him as a key player in the pharmaceutical industry.
Collaborations
Nathan Ide has collaborated with esteemed colleagues such as Hui-Ju J Chen and David A DeGoey. These partnerships have fostered a collaborative environment that enhances the research and development of effective anti-viral therapies.
Conclusion
In summary, Nathan Ide is a prominent inventor whose work on anti-viral compounds is making a significant impact in the fight against Hepatitis C. His contributions to the field, along with his collaborations, highlight the importance of innovation in healthcare.